Medpace Holdings Inc
Fermé
SecteurSoins de santé
458.38 0.52
Résumé
Variation du prix de l'action
24h
Min
455.98
Max
460.92
Revenu | -11M 124M |
|---|---|
Ventes | -1.8M 707M |
P/E Moyenne du Secteur | 29.031 49.712 |
BPA | 4.28 |
Marge bénéficiaire | 17.53 |
Employés | 6,300 |
EBITDA | -9.5M 154M |
Recommandations | Achat |
|---|---|
Prévisions sur 12 Mois | -1.73% downside |
Prochains Résultats | 22 juil. 2026 |
|---|
Capitalisation Boursière | -1.9B 13B |
|---|---|
Ouverture précédente | 457.86 |
Clôture précédente | 458.38 |
Sentiment de l'Actualité
By Acuity
26%
74%
54 / 342 Classement par Healthcare
Medpace Holdings Inc Graphique
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
À Propos Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.